Which fitness trackers are the best for tracking women's health?
The best fitness trackers can be excellent accountability tools in your pursuit of a healthy lifestyle. Whether you've got an Apple Watch, a Garmin, or a FitBit, these small but powerful devices can measure everything from your step count and resting heart rate to your maximal oxygen consumption and sleep patterns.
Women's Health Week
This article is part of Tom's Guide's Women's Health Week — a series of content that explores how technology and the right workouts can support and empower women through every phase of life.
According to a review in the Journal of Medical Internet Research, women make up one of the largest groups of fitness tracker users. Many of these devices measure women-centric statistics like menstrual cycle and pregnancy information, but do they really provide women with useful insights into their own health? Or do they just collect data without any real or helpful context?
Fitness trackers are wearable items, like watches and rings, that record your personal health metrics using a combination of motion sensors, optical heart rate sensors, and user information like height, weight, and age. They can measure your heart rate at rest and during exercise, the total number of steps you've taken in a day, how many calories you burn, and how many hours of deep sleep you get each night, among other metrics.
Many fitness trackers will go even further to provide a deeper look into your overall wellness. Popular trackers from brands like Apple, Garmin, and Woop take the information they record and make estimates on your overall cardiovascular fitness, how much rest and recovery you need, and blood oxygen levels.
Fitness trackers are relatively accurate on stats like distances walked and heart rate trends. Your readings may be a bit off based on how you wear your tracker, but for the most part, these kinds of readings are pretty spot on.
Other measurements, like calories burned, can be less precise. Fitness trackers make estimates based on the data they collect, like your heart rate and activity levels, combined with objective data like your height, weight, and gender. These estimates don't account for body type or muscle mass, which can have a profound impact on the amount of calories you burn.
Cardiovascular fitness measurements can also be a little far from the truth. Accurate VO2 max readings (or the maximum amount of oxygen your body can consume during exercise) are usually recorded using lab equipment and specific tests, whereas fitness tracker VO2 max readings are estimates based on your heart rate levels during exercise and recovery.
While most fitness trackers offer menstrual cycle tracking as a primary feature, that information alone doesn't necessarily provide a full picture of women's health. A few models go well beyond menstrual cycle tracking with options to report discharge characteristics, mood shifts, and pregnancy events like baby kick counts and hiccups.
Garmin fitness trackers offer some of the most detailed women's health insights. Not only can they track cycle dates and phases, but users can continue to track symptoms if periods are irregular or absent due to polycystic ovarian syndrome, menopause, pregnancy and breastfeeding, or contraceptive use. Here's how to use the menstrual tracking feature on your Garmin Watch
Garmin's pregnancy tracking options are also some of the most detailed available, offering gestational age and size estimates, recommendations on prenatal nutrition and exercise, and the ability to enter blood glucose levels for management of gestational diabetes. Here's more about the Garmin pregnancy tracking feature.
The Apple Watch provides a comprehensive look into women's health data as well, featuring temperature-sensing capabilities that can help determine ovulation days and fertile windows. As is the case with other fitness tracker metrics, though, these readings are just estimates.
The Apple Watch also ranked highest in a recent JMIR Formative Research study among women on fitness tracker comfort, features, and motivational qualities.
Fitness trackers can maximize your training potential and help you achieve a variety of health goals.
Until recently, many fitness trackers focused heavily on activity and exercise without much attention to other wellness aspects. However, thanks to advances and upgrades in wearable tracker technology, fitness tracker brands have begun putting women's health needs at the forefront of their features.
How to set up menstrual tracking on your Apple Watch
How to sync your exercises to your menstrual cycle for better workouts
Samsung Galaxy Ring is changing the game for cycle tracking — here's how
Hashtags

Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Yahoo
3 hours ago
- Yahoo
SIGA to Host Business Update Call on August 5, 2025 Following Release of Second-Quarter 2025 Results
NEW YORK, July 29, 2025 (GLOBE NEWSWIRE) -- SIGA Technologies, Inc. (SIGA) (Nasdaq: SIGA), a commercial-stage pharmaceutical company, today announced that management will host a webcast and conference call to provide a business update at 4:30 P.M. ET on Tuesday, August 5, 2025. Participating in the call will be Diem Nguyen, Chief Executive Officer, and Daniel Luckshire, Chief Financial Officer. A live webcast of the call will also be available on the Company's website at in the Investor Relations section of the site, or by clicking here. Please log in approximately 5-10 minutes prior to the scheduled start time. Participants may access the call by dialing 1-800-717-1738 for domestic callers or 1-646-307-1865 for international callers. A replay of the call will be available for two weeks by dialing 1-844-512-2921 for domestic callers or 1-412-317-6671 for international callers and using Conference ID: 1130215. The archived webcast will be available in the Investor Relations section of the Company's website. About SIGA SIGA is a commercial-stage pharmaceutical company and leader in global health focused on the development of innovative medicines to treat and prevent infectious diseases. With a primary focus on orthopoxviruses, we are dedicated to protecting humanity against the world's most severe infectious diseases, including those that occur naturally, accidentally, or intentionally. Through partnerships with governments and public health agencies, we work to build a healthier and safer world by providing essential countermeasures against these global health threats. Our flagship product, TPOXX® (tecovirimat), is an antiviral medicine approved in the U.S. and Canada for the treatment of smallpox and authorized in Europe, the UK, and Japan for the treatment of smallpox, mpox (monkeypox), cowpox, and vaccinia complications. For more information about SIGA, visit Contacts:Suzanne Harnettsharnett@ and Investors Media Jennifer Drew-Bear, Edison GroupJdrew-bear@ Holly Stevens, CG Lifehstevens@
Yahoo
3 hours ago
- Yahoo
Sarepta shares rebound after shipments of gene therapy Elevidys resume in US
(Reuters) -Sarepta Therapeutics shares surged more than 30% before the bell on Tuesday, as analysts said the resumption of U.S. shipments for its muscular gene therapy partially removes financial headwinds and decreases the risk of market withdrawal. The company said on Monday it would resume shipments of Elevidys — approved in the U.S. to treat a rare condition called Duchenne muscular dystrophy — to patients who can walk. U.S. shipments to patients who cannot walk independently are still halted, following the death of two teenage boys earlier this year. These incidents brought heightened regulatory scrutiny to Sarepta in recent weeks, while the pause of shipments raised concerns about the future of Elevidys — the company's largest revenue generator. Sarepta's announcement followed the U.S. Food and Drug Administration's recommendation that the voluntary hold on shipments be removed after a probe showed the death of an 8-year-old boy in Brazil was not related to Elevidys. Wall Street analysts said the resumption of shipments would allow Sarepta to fulfill its near-term payments to partner Arrowhead and maintain access to its debt facilities. "The FDA's recommendation and the resumption of commercial treatment in the U.S. virtually eliminate the risk of Elevidys being formally withdrawn from the market," said William Blair analyst Sami Corwin. While the decision allows some patients to regain access to the treatment, analysts warned that patients and doctors could show hesitancy in light of the recent hit to reputation. "It remains to be seen how the news headlines regarding the patient deaths will affect commercial interest in the near term," Corwin said. Sarepta's partner Roche had also stopped Elevidys shipments in certain countries outside the U.S. Shares of Sarepta surged 36% to $18.85 in premarket trading. They have fallen more than 80% since the first Elevidys-related death was reported in March. Error while retrieving data Sign in to access your portfolio Error while retrieving data Error while retrieving data Error while retrieving data Error while retrieving data


Forbes
3 hours ago
- Forbes
Sweeping Problems Under The Rug By The Feds Doesn't Make Them Go Away
A man walks his dog past a homeless man sleeping under a message painted on a boarded up shop in San ... More Francisco, California on April, 1, 2020, during the novel coronavirus outbreak. - The US death toll from the coronavirus pandemic topped 5,000 late on April 1, according to a running tally from Johns Hopkins University. (Photo by Josh Edelson / AFP) (Photo by JOSH EDELSON/AFP via Getty Images) For decades, every administration, every Congress, put many things off for someone else to deal with. No one can get everything done all the time, that's understandable. But many current economic and social programs aren't a result of juggling what might be possible. Instead, they have become the ultimate attempt to kick every can down the road. That doesn't solve problems. It only hides them and allows them to grow and fester. One of the current examples is homelessness. Here is a statement out of the presidential executive order, Ending Crime And Disorder On America's Streets: 'The overwhelming majority of these individuals are addicted to drugs, have a mental health condition, or both. Nearly two-thirds of homeless individuals report having regularly used hard drugs like methamphetamines, cocaine, or opioids in their lifetimes. An equally large share of homeless individuals reported suffering from mental health conditions.' Homelessness is a problem in many parts of the country. And, yes, people on the streets are often troubled in one way or another. However, the entire executive order is a rhetorical setup, claiming that 'nearly two-thirds' of the individuals reporting having used 'hard drugs like methamphetamines, cocaine, or opioids in their lifetimes.' No source for the statistic that is then delivered to deemphasize that any such use might have been long before. And then a statement that an 'equally large share of homeless individuals reported suffering from mental health conditions.' No source, again, and no explanation of what mental health conditions mean. Broadly defined enough, like any amount of depression, anxiety, discomfort, and so on, it could include everyone in the country. Next, a combination of claiming that spending by the federal government and states has run tens of billions on failed programs 'that address homelessness but not its root causes.' After claiming that homeless people leave 'other citizens vulnerable to public safety threats' comes the statement, 'Shifting homeless individuals into long-term institutional settings for humane treatment through the appropriate use of civil commitment will restore public order.' After stating that previous spending never looked at root causes, presuming that the administration knows the root causes, the proffered solution is to lock people away. The message is to ignore the problem and put it out of sight. The point isn't really for safety, because most dangerous behavior in the country doesn't come from homeless people. It's for comfort and to pretend everything is fine. This has economic and social implications. Institutionalize where? Privately owned prisons where someone makes a lot of money from incarcerations? Hospitals that have been financially struggling but will even more now that Medicaid has been so thoroughly cut? Similar issues come in arguments over diversity, equity, and inclusion, or DEI. The administration wants it purged not only from websites and government discussions, but from corporations, universities, and anywhere else the term might appear. Again, the communication expressed by action is to strike any mention of the topic anywhere, to bury it from consciousness as though that makes issues go away. It never does. Other parts of life are no different. Corporations want to promote the use of the most recent forms of artificial intelligence. Traditionally, the argument executives would use is not that technology was about enabling job cuts, but to free people up to do more useful and interesting work. That mask has finally begun to slip as CEOs and their corporations boast of shrinking their workforces. Ultimately, this will lead to fewer people being employed, greater degrees of consumer financial struggle, and economic weakness. But, again, that all gets brushed under the carpet. No society can long stand with such undermining. So long as problems are ignored, they likely grow worse until there comes a point that they demand more resources than are available.